Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bering Capital is a venture capital firm based in San Francisco, California, specializing in biotech and medical technology investments. The firm was founded to transform innovative ideas into successful ventures, drawing on insights from early Silicon Valley pioneers. Bering Capital focuses on identifying critical problems in healthcare and supporting visionary entrepreneurs.
Bering Capital invests in biotech and medical technology companies, targeting early to growth-stage ventures. The firm emphasizes extraordinary entrepreneurs and innovative solutions that address significant healthcare challenges. Investment sizes and specific check amounts are not disclosed.
Notable portfolio companies include Coherus Oncology, Neuvogen, Cellworks, Onco Response, and CalciMedica. Previous investments include Atea Pharmaceuticals (went public on NASDAQ), Fusion Medical (acquired by Baxter International), Coherus BioSciences (went public on NASDAQ), Invuity (acquired by Stryker Corporation), and Leap Therapeutics (listed on NASDAQ).
Submit your pitch through their website contact form.
Bering Capital focuses on investing in biotech and medical technology companies, emphasizing extraordinary entrepreneurs and innovative healthcare solutions.
Information on whether Bering Capital leads rounds is not specified in the available data.
The firm prefers companies that address critical problems in healthcare, particularly those led by visionary entrepreneurs.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.